Human Growth Hormone Drugs - Global Strategic Business Report 2018: Innovations Hold the Key to Market Growth - ResearchAndMarkets.com

DUBLIN--()--The "Human Growth Hormone Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Human Growth Hormone Drugs in US$ Million.

The report profiles 28 companies including many key and niche players such as:

  • Eli Lilly and Company (US)
  • Ferring Holding SA (Switzerland)
  • Genentech, Inc. (US)
  • GeneScience Pharmaceuticals Co., Ltd. (China)
  • Merck KGaA (Germany)
  • Novo Nordisk A/S (Denmark)
  • Pfizer, Inc. (US)
  • Sandoz International GmbH (Germany)

Key Topics Covered

1. INDUSTRY OVERVIEW

2. MARKET TRENDS & ISSUES

  • Pediatric GHD Rules, while Adult GHD Remains Underserved
  • Long-Acting hGH Drugs - A Potential Game Changer
  • Select Long-Acting hGH Products in Pipeline by Development Stage
  • Biosimilars Create Little Impact, Further Validation to Expand Indications and Growth
  • Manufacturers Bet on Novel Drug Delivery Technologies
  • Phase IV Studies Necessitated for First Biosimilars
  • Needle-less Drug Delivery Systems to Wipe Out of Syringes
  • Drug Delivery Device Options for Marketed hGH Products
  • Growing Non-Prescription/Off-Label Usage - A Potential Health Hazard
  • Oral hGH Secretagogues - An Alternative to Controversial hGH Injections in Professional Sports
  • Risk of Cancer Necessitates Judicious Use of hGH in Children
  • Dose Titration - A Key to Achieve Enhanced Tolerability
  • Growth Concerns about Prolonged Usage of Growth Hormones

3. COMPETITIVE LANDSCAPE

4. HUMAN GROWTH HORMONE: AN OVERVIEW

5. RECENT INDUSTRY ACTIVITY

6. FOCUS ON SELECT GLOBAL PLAYERS

7. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 28 (including Divisions/Subsidiaries 33)

  • The United States (10)
  • Canada (1)
  • Japan (2)
  • Europe (10)
    • Germany (4)
    • The United Kingdom (2)
    • Rest of Europe (4)
  • Asia-Pacific (Excluding Japan) (9)
  • Middle East (1)

For more information about this report visit https://www.researchandmarkets.com/research/kpntl7/human_growth?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Endocrine and Metabolic Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Endocrine and Metabolic Disorders Drugs